Storia in 2 fonti

Aspen Pharmacare and MSD partner for innovative HIV prevention medicine

Aspen Pharmacare has secured a licensing agreement with MSD for alimatravir, a promising once-monthly oral medication aimed at preventing HIV-1, which could revolutionise access to HIV prevention in South Africa.

Raccontata da

iol.co.za

businessday.co.za

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

iol.co.zaStai leggendo21 h fa

Aspen Pharmacare and MSD partner for innovative HIV prevention medicine

originale

businessday.co.za17 h fa

Aspen gets Merck licensing agreement to make lower-cost HIV pill

Seven generic drug manufacturers sign royalty-free agreements to produce experimental once-monthly HIV pill

Leggi questa versione → originale

Timeline cronologica

venerdì 24 luglio 2026·iol.co.za
Aspen Pharmacare and MSD partner for innovative HIV prevention medicine
Aspen Pharmacare has secured a licensing agreement with MSD for alimatravir, a promising once-monthly oral medication aimed at preventing HIV-1, which could revolutionise access…
venerdì 24 luglio 2026·businessday.co.za
Aspen gets Merck licensing agreement to make lower-cost HIV pill
Seven generic drug manufacturers sign royalty-free agreements to produce experimental once-monthly HIV pill